- Home
- NXTT vs NCNA Comparison
NXTT vs NCNA Comparison
Compare NXTT & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTT
- NCNA
- Stock Information
- Founded
- NXTT 2019
- NCNA 1997
- Country
- NXTT China
- NCNA United Kingdom
- Employees
- NXTT N/A
- NCNA N/A
- Industry
- NXTT
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- NXTT
- NCNA Health Care
- Exchange
- NXTT NYSE
- NCNA Nasdaq
- Market Cap
- NXTT 3.5M
- NCNA 3.4M
- IPO Year
- NXTT N/A
- NCNA 2017
- Fundamental
- Price
- NXTT $0.25
- NCNA $0.79
- Analyst Decision
- NXTT
- NCNA Buy
- Analyst Count
- NXTT 0
- NCNA 2
- Target Price
- NXTT N/A
- NCNA $25.00
- AVG Volume (30 Days)
- NXTT 358.8K
- NCNA 122.9K
- Earning Date
- NXTT 05-19-2025
- NCNA 05-15-2025
- Dividend Yield
- NXTT N/A
- NCNA N/A
- EPS Growth
- NXTT N/A
- NCNA N/A
- EPS
- NXTT 3.73
- NCNA N/A
- Revenue
- NXTT $1,800,000.00
- NCNA N/A
- Revenue This Year
- NXTT N/A
- NCNA N/A
- Revenue Next Year
- NXTT N/A
- NCNA N/A
- P/E Ratio
- NXTT $0.08
- NCNA N/A
- Revenue Growth
- NXTT N/A
- NCNA N/A
- 52 Week Low
- NXTT $0.26
- NCNA $0.69
- 52 Week High
- NXTT $6.59
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- NXTT 25.68
- NCNA 45.45
- Support Level
- NXTT $0.28
- NCNA $0.81
- Resistance Level
- NXTT $0.32
- NCNA $0.98
- Average True Range (ATR)
- NXTT 0.03
- NCNA 0.14
- MACD
- NXTT 0.04
- NCNA 0.00
- Stochastic Oscillator
- NXTT 0.00
- NCNA 20.08
About NXTT NEXT TECHNOLOGY HOLDING INC
Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.